Market Overview:
The global drug of abuse (DOA) testing equipment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of drug abuse, growing demand for accurate and rapid test results, and rising awareness about the benefits of early diagnosis and treatment. The global DOA testing equipment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into immunoassay analyzers, chromatography instruments, breath analyzers, and others. Immunoassay analyzers held a dominant share in 2017 owing to their high accuracy levels and ability to detect a wide range of drugs. On the basis of application, hospitals accounted for a major share in 2017 due to rising demand for early diagnosis and treatment options for drug abusers.
 Testing Equipment Industry Outlook.svg)
Product Definition:
Drug of Abuse (DOA) Testing Equipment is used to detect the presence of drugs in a person's system. It is important for employers to use this equipment to test their employees for drug use, as it can help ensure safety in the workplace.
Immunoassay analyzers:
Immunoassay analyzers are instruments used for the detection of specific antibodies in biological fluids. They work by detecting and measuring the presence of an antigen-antibody response in patients suffering from a disease or medical condition. The most common use of immunoassay analyzers is to detect diseases such as HIV, cancer, autoimmune disorders, infectious diseases like H1N1 and other viral infections like HCV & HPV.
Chromatography instruments:
The global chromatography instruments and it's usage in drug of abuse testing market size was valued at USD 652.5 million in 2016. It is expected to witness a CAGR of XX% during the forecast period, owing to increasing prevalence of substance abuse globally and need for rapid, accurate & sensitive detection methods for monitoring changes associated with it.
Application Insights:
Based on the application, the global market is segmented into hospitals, laboratories, workplace and at-home. Hospitals held the largest share in 2017 owing to high usage of drugs of abuse by patients for medical purposes such as pain management and anxiety disorders. Moreover, increasing number of detoxification centers is expected to drive demand for drug testing in hospitals over the forecast period.
The laboratory sector is anticipated to witness significant growth over the forecast period due to wide-spread use of DOA analyzers across various applications such as toxicology testing and clinical pathology tests. Increasing government regulations regarding safety procedures along with rising awareness about drug abuse among healthcare professionals are some factors that may drive market growth in this segment during future years.
The workplace segment also holds a considerable share owing to growing awareness about substance abuse among employees coupled with an increase in random alcohol & drug tests conducted by companies or organizations hiring new employees.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. This can be attributed to increasing substance abuse, rising number of DOAEs tests, and growing awareness about these tests among patients as well as physicians. The region has a large base of drug users who are looking for quick & easy ways to procure drugs. These factors have led to high demand for such testing equipment in this region.
The Asia Pacific market is also anticipated to witness significant growth over the forecast period owing to an increase in government initiatives related with drug abuse testing across various countries including China, Australia, Japan, Singapore and India amongst others; which will drive industry expansion over this region during 2018 - 2030 periods.
Growth Factors:
- Increasing demand for drug of abuse testing equipment due to increasing incidences of drug abuse
- Growing awareness about the harmful effects of drugs and their impact on human health
- Stringent government regulations and norms pertaining to drug abuse testing equipment
- Technological advancements in the field of drug abuse testing equipment that help improve accuracy and efficiency
- Rising demand for point-of-care (POC) devices for rapid, on-the-spot detection of drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug of Abuse (DOA) Testing Equipment Market Research Report
By Type
Immunoassay analyzers, Chromatography instruments, Breath analyzers, Others
By Application
Hospitals, Laboratories, Workplace, At-Home
By Companies
Siemens AG, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics, Express Diagnostics Int'l, Psychemedics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Drug of Abuse (DOA) Testing Equipment Market Report Segments:
The global Drug of Abuse (DOA) Testing Equipment market is segmented on the basis of:
Types
Immunoassay analyzers, Chromatography instruments, Breath analyzers, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Laboratories, Workplace, At-Home
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens AG
- Merck
- Roche
- Thermo Fisher Scientific
- Bio-Rad
- Abbott
- Quest Diagnostics
- Express Diagnostics Int'l
- Psychemedics
 Testing Equipment Market Overview.svg)
Highlights of The Drug of Abuse (DOA) Testing Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoassay analyzers
- Chromatography instruments
- Breath analyzers
- Others
- By Application:
- Hospitals
- Laboratories
- Workplace
- At-Home
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug of Abuse (DOA) Testing Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Equipment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug of Abuse (DOA) testing equipment is a device used to detect the presence of drugs in a person's body. It can be used to test for substances such as cocaine, marijuana, and methamphetamine.
Some of the key players operating in the drug of abuse (doa) testing equipment market are Siemens AG, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics, Express Diagnostics Int'l, Psychemedics.
The drug of abuse (doa) testing equipment market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug of Abuse (DOA) Testing Equipment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug of Abuse (DOA) Testing Equipment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug of Abuse (DOA) Testing Equipment Market - Supply Chain
4.5. Global Drug of Abuse (DOA) Testing Equipment Market Forecast
4.5.1. Drug of Abuse (DOA) Testing Equipment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug of Abuse (DOA) Testing Equipment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug of Abuse (DOA) Testing Equipment Market Absolute $ Opportunity
5. Global Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Type
5.3.1. Immunoassay analyzers
5.3.2. Chromatography instruments
5.3.3. Breath analyzers
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Laboratories
6.3.3. Workplace
6.3.4. At-Home
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug of Abuse (DOA) Testing Equipment Demand Share Forecast, 2019-2026
9. North America Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Laboratories
9.4.3. Workplace
9.4.4. At-Home
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Type
9.7.1. Immunoassay analyzers
9.7.2. Chromatography instruments
9.7.3. Breath analyzers
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug of Abuse (DOA) Testing Equipment Demand Share Forecast, 2019-2026
10. Latin America Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Laboratories
10.4.3. Workplace
10.4.4. At-Home
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Type
10.7.1. Immunoassay analyzers
10.7.2. Chromatography instruments
10.7.3. Breath analyzers
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug of Abuse (DOA) Testing Equipment Demand Share Forecast, 2019-2026
11. Europe Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Laboratories
11.4.3. Workplace
11.4.4. At-Home
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Type
11.7.. Immunoassay analyzers
11.7.2. Chromatography instruments
11.7.3. Breath analyzers
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug of Abuse (DOA) Testing Equipment Demand Share, 2019-2026
12. Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Laboratories
12.4.3. Workplace
12.4.4. At-Home
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Type
12.7.1. Immunoassay analyzers
12.7.2. Chromatography instruments
12.7.3. Breath analyzers
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug of Abuse (DOA) Testing Equipment Demand Share, 2019-2026
13. Middle East & Africa Drug of Abuse (DOA) Testing Equipment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Laboratories
13.4.3. Workplace
13.4.4. At-Home
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug of Abuse (DOA) Testing Equipment Market Size and Volume Forecast by Type
13.7.1. Immunoassay analyzers
13.7.2. Chromatography instruments
13.7.3. Breath analyzers
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug of Abuse (DOA) Testing Equipment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug of Abuse (DOA) Testing Equipment Market: Market Share Analysis
14.2. Drug of Abuse (DOA) Testing Equipment Distributors and Customers
14.3. Drug of Abuse (DOA) Testing Equipment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siemens AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abbott
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Quest Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Express Diagnostics Int'l
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Psychemedics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
